# BROMPHENIRAMINE MALEATE, PSEUDOEPHEDRINE HYDROCHLORIDE AND DEXTROMETHORPHAN HYDROBROMIDE
> **ANDA202955** · Abbreviated New Drug Application (Generic) · Sponsor: RHODES PHARMS · Approved 2020-11-05
## Drug
- **FDA Application Number:** ANDA202955
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** BROMPHENIRAMINE MALEATE, PSEUDOEPHEDRINE HYDROCHLORIDE AND DEXTROMETHORPHAN HYDROBROMIDE
- **Generic name:** Brompheniramine Maleate
- **Active ingredients:** BROMPHENIRAMINE MALEATE; DEXTROMETHORPHAN HYDROBROMIDE; PSEUDOEPHEDRINE HYDROCHLORIDE
- **Dosage form:** SYRUP
- **Route:** ORAL
- **Marketing status:** Discontinued
- **Sponsor:** RHODES PHARMS
- **First approval:** 2020-11-05
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=202955)
---
*AI Analytics · CC0 1.0*